Clinical Trial Update: First Time in Human Study (FTIH) With Positron Emission Tomography (PET) [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study using PET imaging for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED